Pressure Biosciences Analysis
| PBIODelisted Stock | USD 0.49 0.00 0.00% |
Pressure Biosciences is overvalued with Real Value of 0.47 and Hype Value of 0.49. The main objective of Pressure Biosciences otc analysis is to determine its intrinsic value, which is an estimate of what Pressure Biosciences is worth, separate from its market price. There are two main types of Pressure Biosciences' stock analysis: fundamental analysis and technical analysis.
The Pressure Biosciences otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Pressure |
Pressure OTC Stock Analysis Notes
The company recorded a loss per share of 2.59. Pressure Biosciences last dividend was issued on the 5th of June 2017. The entity had 1:30 split on the 5th of June 2017. Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. As of August 2, 2022, Pressure BioSciences, Inc. operates as a subsidiary of Emergent Health Corp. Pressure Biosciences operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 12 people.The quote for Pressure Biosciences is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Pressure Biosciences contact Richard Schumacher at 508 230 1828 or learn more at https://www.pressurebiosciences.com.Pressure Biosciences Investment Alerts
| Pressure Biosciences is not yet fully synchronised with the market data | |
| Pressure Biosciences has some characteristics of a very speculative penny stock | |
| Pressure Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Pressure Biosciences currently holds 150 K in liabilities with Debt to Equity (D/E) ratio of 2.04, implying the company greatly relies on financing operations through barrowing. Pressure Biosciences has a current ratio of 0.07, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Pressure Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Pressure Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pressure Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pressure to invest in growth at high rates of return. When we think about Pressure Biosciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2 M. Net Loss for the year was (20.15 M) with profit before overhead, payroll, taxes, and interest of 1.06 M. | |
| Pressure Biosciences currently holds about 121.57 K in cash with (4.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
Pressure Biosciences Upcoming and Recent Events
Earnings reports are used by Pressure Biosciences to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 10th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Pressure Biosciences Thematic Classifications
In addition to having Pressure Biosciences otc stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Measuring and Control EquipmentUSA Equities from Measuring and Control Equipment industry as classified by Fama & French |
Pressure Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.22 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pressure Biosciences's market, we take the total number of its shares issued and multiply it by Pressure Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Pressure Biosciences Outstanding Bonds
Pressure Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pressure Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pressure bonds can be classified according to their maturity, which is the date when Pressure Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Prestige Brands 5125 Corp BondUS74112BAL99 | View | |
| US74112BAM72 Corp BondUS74112BAM72 | View |
About Pressure OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Pressure Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pressure shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Pressure Biosciences. By using and applying Pressure OTC Stock analysis, traders can create a robust methodology for identifying Pressure entry and exit points for their positions.
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. As of August 2, 2022, Pressure BioSciences, Inc. operates as a subsidiary of Emergent Health Corp. Pressure Biosciences operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 12 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Pressure Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Pressure OTC Stock
If you are still planning to invest in Pressure Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pressure Biosciences' history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |